Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Narayana HrudayalayaNSE:NH -0.95%95 EV-to-EBITDA is 22.47 as of Aug. 13, 2026, which is 1% above its 10-year median of 22.29. GuruFocus rates NSE:NH with a GF Score™ of 95/100 and a GF Value™ of ₹2,430.10 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 512 Healthcare Providers & Services companies, Narayana Hrudayalaya ranks worse than 79.3% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Narayana Hrudayalaya's enterprise value is ₹405,201 Mil.
Narayana Hrudayalaya's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹18,033 Mil. Therefore, Narayana Hrudayalaya's EV-to-EBITDA for today is 22.47.
The historical rank and industry rank for Narayana Hrudayalaya's EV-to-EBITDA or its related term are showing as below:
NSE:NH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.9 Med: 22.29 Max: 70.02
Current: 22.47
During the past 13 years, the highest EV-to-EBITDA of Narayana Hrudayalaya was 70.02. The lowest was 10.90. And the median was 22.29.
NSE:NH's EV-to-EBITDA is ranked worse than 79.3% of 512
companies
in the Healthcare Providers & Services industry
Industry Median: 10.835
vs NSE:NH: 22.47
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Narayana Hrudayalaya's PE Ratio (TTM) for today is calculated as:
Narayana Hrudayalaya's share price for today is ₹1831.30.
Narayana Hrudayalaya's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹40.180.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Narayana Hrudayalaya's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Narayana Hrudayalaya's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Narayana Hrudayalaya EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Narayana Hrudayalaya's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Narayana Hrudayalaya's EV-to-EBITDA falls into.
Narayana Hrudayalaya's current Enterprise Value is ₹405,201 Mil.
Narayana Hrudayalaya's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹18,033 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Narayana Hrudayalaya (NSE:NH) has a EV-to-EBITDA of 22.47 as of Aug. 13, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Narayana Hrudayalaya. This is near median its historical median of 22.29. Over the past decade, Narayana Hrudayalaya's EV-to-EBITDA has ranged from 10.90 to 70.02. According to the industry distribution chart, Narayana Hrudayalaya ranks #406 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 79.3%.
Is Narayana Hrudayalaya's EV-to-EBITDA too high?
Narayana Hrudayalaya's current EV-to-EBITDA of 22.47 is near median its 10-year median of 22.29. Over the past 10 years, this metric has ranged from a low of 10.90 to a high of 70.02. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.84. Narayana Hrudayalaya's value of 22.47 is 107.4% above this industry median. Based on the distribution chart, Narayana Hrudayalaya ranks #406 out of 512 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Narayana Hrudayalaya has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Narayana Hrudayalaya's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Narayana Hrudayalaya ranks #406 out of 512 companies for EV-to-EBITDA. This places Narayana Hrudayalaya in the lower half of its industry. The industry median EV-to-EBITDA is 10.84. Narayana Hrudayalaya's value of 22.47 is 107.4% above this benchmark. Historically, Narayana Hrudayalaya's own EV-to-EBITDA has ranged from 10.90 to 70.02 over the past decade. While the company's 10-year median is 22.29 vs. the industry median of 10.84, Narayana Hrudayalaya has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.84, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Narayana Hrudayalaya's current EV-to-EBITDA of 22.47 is 107.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Narayana Hrudayalaya. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Narayana Hrudayalaya's current EV-to-EBITDA is 22.47, which is near median its own 10-year median of 22.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Narayana Hrudayalaya stock overvalued right now?
Based on GuruFocus' analysis, Narayana Hrudayalaya (NSE:NH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,430.10, compared to a current price of ₹1,831.30 — trading 24.6% below its estimated fair value. The current EV-to-EBITDA is 22.47, which is near median its 10-year median of 22.29 and 107.4% above the Healthcare Providers & Services industry median of 10.84. Narayana Hrudayalaya's overall GF Score™ is 95/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Narayana Hrudayalaya (NSE:NH), the current EV-to-EBITDA is 22.47 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Narayana Hrudayalaya (NSE:NH) Overvalued in 2026?
Based on GuruFocus' analysis, Narayana Hrudayalaya stock appears to be undervalued.
The current stock price of ₹1,831.30 is trading 24.6% below its estimated GF Value™ of ₹2,430.10.
GuruFocus considers Narayana Hrudayalaya to be Modestly Undervalued.
Key valuation signals for NSE:NH:
EV-to-EBITDA: 22.47 (near median its 10-year median of 22.29)
GF Value™: ₹2,430.10 vs. price of ₹1,831.30 (24.6% below fair value)
Industry Position: 107.4% above the Healthcare Providers & Services median (#406 of 512)
No single metric tells the full story. See the NSE:NH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Narayana Hrudayalaya Ltd is an India-based medical and healthcare service provider. The company is engaged in the business of running and operating hospitals, clinics, health centers, nursing homes, and other related activities. The Company's sole operating segment is Medical and Healthcare Related Services. It also provides surgery services such as Cardiac Surgery, nephrology, urology, neurology, neurosurgery, endocrinology, orthopaedics, internal medicine, obstetrics, gynaecology, paediatrics, neonatology, gastroenterology, and oncology. It has business operations in India and the Rest of the world, of which the maximum revenue is generated from the business operations in India.
95GF Score
Get the complete analysis for NSE:NH
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NH has been successfully added to your 
